Vaccinazione anti-papillomavirus

Nuove prospettive nelle donne adulte

Translated title of the contribution: Perspectives of HPV vaccination in mid-adult women

L. Mariani, E. Baiocco, E. Mancini, E. Vizza

Research output: Contribution to journalArticle

Abstract

Perspectives of HPV vaccination in mid-adult women. Vaccination against human papillomavirus (HPV) represents an important step in the control of HPV infection and related cancers. Although worldwide primary target of vaccination programs is the adolescent girl, yet significant benefits can still be obtained in non-naïve sexually-active older women with encouraging clinical data up to the age of 45 years. Better understanding of the natural history of HPV diseases across different age groups is still needed. Nevertheless, HPV acquisition continues throughout life and, although persistence might not be comparable in older women when compared to their younger counterparts, HPV associated cancers still occur as well as benign lesions such as genital warts. Existing data show the efficacy and safety of vaccines beyond 25 years old, in both naïve and non-naïve women. Considering known epidemiological features of HPV diseases in midadult women, current evidence calls for further considerations of on-demand vaccination of women up to 45 years of age.

Original languageItalian
Pages (from-to)157-165
Number of pages9
JournalItalian Journal of Gynaecology and Obstetrics
Volume22
Issue number3
Publication statusPublished - 2010

Fingerprint

Vaccination
Condylomata Acuminata
Papillomavirus Infections
Natural History
Neoplasms
Vaccines
Age Groups
Safety

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Vaccinazione anti-papillomavirus : Nuove prospettive nelle donne adulte. / Mariani, L.; Baiocco, E.; Mancini, E.; Vizza, E.

In: Italian Journal of Gynaecology and Obstetrics, Vol. 22, No. 3, 2010, p. 157-165.

Research output: Contribution to journalArticle

@article{91e605f718224ed986d560b46a1b1e5a,
title = "Vaccinazione anti-papillomavirus: Nuove prospettive nelle donne adulte",
abstract = "Perspectives of HPV vaccination in mid-adult women. Vaccination against human papillomavirus (HPV) represents an important step in the control of HPV infection and related cancers. Although worldwide primary target of vaccination programs is the adolescent girl, yet significant benefits can still be obtained in non-na{\"i}ve sexually-active older women with encouraging clinical data up to the age of 45 years. Better understanding of the natural history of HPV diseases across different age groups is still needed. Nevertheless, HPV acquisition continues throughout life and, although persistence might not be comparable in older women when compared to their younger counterparts, HPV associated cancers still occur as well as benign lesions such as genital warts. Existing data show the efficacy and safety of vaccines beyond 25 years old, in both na{\"i}ve and non-na{\"i}ve women. Considering known epidemiological features of HPV diseases in midadult women, current evidence calls for further considerations of on-demand vaccination of women up to 45 years of age.",
keywords = "Adult women, Age, HPV, Vaccination",
author = "L. Mariani and E. Baiocco and E. Mancini and E. Vizza",
year = "2010",
language = "Italian",
volume = "22",
pages = "157--165",
journal = "Italian Journal of Gynaecology and Obstetrics",
issn = "1121-8339",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "3",

}

TY - JOUR

T1 - Vaccinazione anti-papillomavirus

T2 - Nuove prospettive nelle donne adulte

AU - Mariani, L.

AU - Baiocco, E.

AU - Mancini, E.

AU - Vizza, E.

PY - 2010

Y1 - 2010

N2 - Perspectives of HPV vaccination in mid-adult women. Vaccination against human papillomavirus (HPV) represents an important step in the control of HPV infection and related cancers. Although worldwide primary target of vaccination programs is the adolescent girl, yet significant benefits can still be obtained in non-naïve sexually-active older women with encouraging clinical data up to the age of 45 years. Better understanding of the natural history of HPV diseases across different age groups is still needed. Nevertheless, HPV acquisition continues throughout life and, although persistence might not be comparable in older women when compared to their younger counterparts, HPV associated cancers still occur as well as benign lesions such as genital warts. Existing data show the efficacy and safety of vaccines beyond 25 years old, in both naïve and non-naïve women. Considering known epidemiological features of HPV diseases in midadult women, current evidence calls for further considerations of on-demand vaccination of women up to 45 years of age.

AB - Perspectives of HPV vaccination in mid-adult women. Vaccination against human papillomavirus (HPV) represents an important step in the control of HPV infection and related cancers. Although worldwide primary target of vaccination programs is the adolescent girl, yet significant benefits can still be obtained in non-naïve sexually-active older women with encouraging clinical data up to the age of 45 years. Better understanding of the natural history of HPV diseases across different age groups is still needed. Nevertheless, HPV acquisition continues throughout life and, although persistence might not be comparable in older women when compared to their younger counterparts, HPV associated cancers still occur as well as benign lesions such as genital warts. Existing data show the efficacy and safety of vaccines beyond 25 years old, in both naïve and non-naïve women. Considering known epidemiological features of HPV diseases in midadult women, current evidence calls for further considerations of on-demand vaccination of women up to 45 years of age.

KW - Adult women

KW - Age

KW - HPV

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=78649602322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649602322&partnerID=8YFLogxK

M3 - Articolo

VL - 22

SP - 157

EP - 165

JO - Italian Journal of Gynaecology and Obstetrics

JF - Italian Journal of Gynaecology and Obstetrics

SN - 1121-8339

IS - 3

ER -